Fundraising Fox

Epiwatch

Baltimore, US · Founded 2020 · Delaware corporation · 3 known investors

EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.

Digital HealthHealthtechMedical Devices

Founders & leadership

Epiwatch was founded in 2020 by Nathan Crone and Gregory Krauss.

NC
Nathan CroneCo-founder
GK
Gregory KraussCo-founder
TP
Teresa PregoExecutive
DP
Dean PapadopoulosNamed on SEC filing

Board

DH
Daniel HanleyBoard director
RS
Richard SchmittBoard director
RT
Richard ThomasBoard director
ME
Michael E. SingerBoard director
RS
Robert SmithBoard director

Investors · 3

Iaso VenturesCambridge
Maryland TEDCOUpper Marlboro · $500K – $1.5M
TEDCOColumbia

Reported raises · per SEC filings

Form D private placements

$2.3M disclosed across 8 of 11 rounds · 2021–2026

▶$500KofferedAug 2026 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Richard SchmittDirector
  • Teresa PregoExecutive Officer, Director
  • Robert SmithDirector
Offering amount
$500K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KofferedJul 2026 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Richard SchmittDirector
  • Teresa PregoExecutive Officer, Director
  • Robert SmithDirector
Offering amount
$300K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KofferedSep 2025 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Teresa PregoExecutive Officer, Director
  • Richard ThomasDirector
  • Robert SmithDirector
  • Richard SchmittDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Daniel HanleyDirector
Offering amount
$750K
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$190KraisedOct 2024 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard SchmittDirector
  • Daniel HanleyDirector
  • Robert SmithDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Michael E. SingerDirector
  • Richard ThomasDirector
  • Teresa PregoExecutive Officer, Director
Amount sold
$190K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJul 2024 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HanleyDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Richard SchmittDirector
  • Richard ThomasDirector
  • Teresa PregoExecutive Officer, Director
  • Michael E. SingerDirector
Offering amount
$850K
Amount sold
$250K
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedJan 2024 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard SchmittDirector
  • Michael E. SingerDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Richard ThomasDirector
  • Daniel HanleyDirector
Offering amount
$750K
Amount sold
$300K
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55KraisedNov 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel HanleyDirector
  • Michael E. SingerDirector
  • Richard ThomasDirector
  • Richard SchmittDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
Offering amount
$400K
Amount sold
$55K
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$340KraisedJun 2023 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard ThomasDirector
  • Dean PapadopoulosExecutive Officer, Director, Promoter
  • Michael E. SingerDirector
  • Daniel HanleyDirector
  • Richard SchmittDirector
Offering amount
$375K
Amount sold
$340K
First sale
Jun 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Empatica132 shared keywordsEmpatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.
Aha119 shared keywordsContent references the American Hospital Association's national advisory work on cybersecurity and risk for the U.S. healthcare field, including analysis of cyberattacks targeting hospitals and health systems.

Companies competing with Epiwatch for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Epiwatch do?
EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.
Who founded Epiwatch?
Epiwatch was founded by Nathan Crone, Gregory Krauss in 2020.
Who are Epiwatch's investors?
Epiwatch's investors include Iaso Ventures, Maryland TEDCO, TEDCO.
How much funding has Epiwatch raised?
Epiwatch has disclosed $2.3M raised across 8 of its 11 known rounds.
Where is Epiwatch headquartered?
Epiwatch is headquartered in Baltimore, US.